- Home
- LEVI vs RNA Comparison
LEVI vs RNA Comparison
Compare LEVI & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEVI
- RNA
- Stock Information
- Founded
- LEVI 1853
- RNA 2012
- Country
- LEVI United States
- RNA United States
- Employees
- LEVI N/A
- RNA N/A
- Industry
- LEVI Apparel
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- LEVI Consumer Discretionary
- RNA Health Care
- Exchange
- LEVI Nasdaq
- RNA Nasdaq
- Market Cap
- LEVI 6.8B
- RNA 5.5B
- IPO Year
- LEVI 2019
- RNA 2020
- Fundamental
- Price
- LEVI $16.57
- RNA $42.18
- Analyst Decision
- LEVI Buy
- RNA Strong Buy
- Analyst Count
- LEVI 9
- RNA 9
- Target Price
- LEVI $22.78
- RNA $63.22
- AVG Volume (30 Days)
- LEVI 1.9M
- RNA 1.1M
- Earning Date
- LEVI 10-02-2024
- RNA 11-07-2024
- Dividend Yield
- LEVI 3.14%
- RNA N/A
- EPS Growth
- LEVI N/A
- RNA N/A
- EPS
- LEVI 0.38
- RNA N/A
- Revenue
- LEVI $6,157,900,000.00
- RNA $10,117,000.00
- Revenue This Year
- LEVI $3.04
- RNA $19.33
- Revenue Next Year
- LEVI $4.51
- RNA $10.35
- P/E Ratio
- LEVI $43.67
- RNA N/A
- Revenue Growth
- LEVI 0.53
- RNA N/A
- 52 Week Low
- LEVI $14.71
- RNA $5.68
- 52 Week High
- LEVI $24.34
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- LEVI 28.90
- RNA 42.17
- Support Level
- LEVI $16.76
- RNA $45.65
- Resistance Level
- LEVI $17.24
- RNA $56.00
- Average True Range (ATR)
- LEVI 0.36
- RNA 3.33
- MACD
- LEVI 0.02
- RNA 0.07
- Stochastic Oscillator
- LEVI 8.57
- RNA 7.12
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.